Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis

[1]  Kathleen A Cronin,et al.  The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. , 2014, Cancer.

[2]  U. Guller,et al.  Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients , 2012, British Journal of Cancer.

[3]  J. Huh,et al.  Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: are they comparable? , 2011, Surgery.

[4]  Gary King,et al.  MatchIt: Nonparametric Preprocessing for Parametric Causal Inference , 2011 .

[5]  Shung-Haur Yang,et al.  Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer , 2011, International Journal of Colorectal Disease.

[6]  S. Sukumar*,et al.  C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management. , 2011, Journal of the National Cancer Institute.

[7]  G. Choi,et al.  Serum Carcinoembryonic Antigen Monitoring After Curative Resection for Colorectal Cancer: Clinical Significance of the Preoperative Level , 2009, Annals of Surgical Oncology.

[8]  H. Shimada,et al.  Preoperative Serum Carcinoembryonic Antigen Level as a Predictive Factor of Recurrence After Curative Resection of Colorectal Cancer , 2008, Annals of Surgical Oncology.

[9]  D. Kerr,et al.  Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study , 2007, The Lancet.

[10]  B. Hansen,et al.  Optimal Full Matching and Related Designs via Network Flows , 2006 .

[11]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[12]  E. Mitchell,et al.  Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer , 2005, Cancer investigation.

[13]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[14]  Daniel J Sargent,et al.  Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Hannah K. Weir,et al.  Building the infrastructure for nationwide cancer surveillance and control – a comparison between The National Program of Cancer Registries (NPCR) and The Surveillance, Epidemiology, and End Results (SEER) Program (United States) , 2003, Cancer Causes & Control.

[16]  Carolyn Compton,et al.  American Joint Committee on Cancer prognostic factors consensus conference , 2000, Cancer.

[17]  P. Rosenbaum,et al.  Invited commentary: propensity scores. , 1999, American journal of epidemiology.

[18]  K. Choe,et al.  Prognostic Factors in 2230 Korean Colorectal Cancer Patients: Analysis of Consecutively Operated Cases , 1999, World Journal of Surgery.

[19]  J. Guillem,et al.  Stage I rectal cancer: identification of high-risk patients. , 1998, Journal of the American College of Surgeons.

[20]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[21]  J. Guillem,et al.  Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. , 1997, Journal of the American College of Surgeons.

[22]  J. Reed,et al.  Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma , 1997, Diseases of the colon and rectum.

[23]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[24]  G. Tzanakakis,et al.  Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production , 1993, Cancer.

[25]  K. Westbrook,et al.  Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence. , 1991, Archives of surgery.

[26]  I. Fidler,et al.  Growth potential of human colorectal carcinomas in nude mice: association with the preoperative serum concentration of carcinoembryonic antigen in patients. , 1988, Cancer research.

[27]  P. Rosenbaum.  Model-Based Direct Adjustment , 1987 .

[28]  J. O'fallon,et al.  The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer , 1986, Cancer.

[29]  N. Wolmark,et al.  The Prognostic Significance of Preoperative Carcinoembryonic Antigen Levels in Colorectal Cancer: Results from NSABP Clinical Trials , 1984 .

[30]  S. Ellenberg,et al.  CEA Monitoring Among Patients in Multi‐institutional Adjuvant G.I. Therapy Protocols , 1982, Annals of surgery.

[31]  R. G. Hoffman,et al.  Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. , 1978, The New England journal of medicine.

[32]  Mckenzie Shaun,et al.  アジュバント化学療法は米国対がん合同委員会(American Joint Committee on Cancer)の病期分類による第II期結腸癌患者の生残率を改善する , 2011 .

[33]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[34]  A. Jaffe,et al.  Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomised study. , 1983, British heart journal.